
BioNexus Gene Lab Corp (BGLC)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy BGLC Stock
Start investing in BGLC
About BioNexus Gene Lab Corp (BGLC)
Market cap | $4.96M |
Today's volume | 15.69K |
Revenue (TTM) | $9.27M |
Avg. daily volume | 648.73K |
EBITDA (TTM) | -$2.13M |
Open | $2.77 |
Price / earnings ratio | -2.35x |
Today's range | $2.77 - $2.96 |
Debt / equity | 2.57x |
52 week range | $2.01 - $8.4 |
5 year debt / equity | 1.05x |
Beta (LTM) | 0.14x |
Interest coverage | -92.54x |
Dividend & yield | $0.00 (0.00%) |
Current ratio | 4.19x |
Ex-dividend date | — |
Next earnings | Aug 13, 2025 |
Dividend payable date | — |
BGLC Stock News
View all



Frequently Asked Questions (FAQ)
How to buy BGLC stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in BGLC stock
Navigate to the Explore page. Then, type BGLC into the search bar. When you see BGLC stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased BGLC stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
BioNexus Gene Lab Corp Stock Earnings
The value each BGLC share was expected to gain vs. the value that each BGLC share actually gained.
BGLC (BGLC) reported earnings per share (EPS) of $0, — estimates of $0 by —. In the same quarter last year, BGLC's earnings per share (EPS) was $0. BGLC is expected to release next earnings on 08/13/2025, with an earnings per share (EPS) estimate of $0.